Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.

In Alzheimer disease (AD) patients, early memory dysfunction is associated with glucose hypometabolism and neuronal loss in the hippocampus. Double transgenic (Tg) mice co-expressing the M146L presenilin 1 (PS1) and K670N/M671L, the double "Swedish" amyloid precursor protein (APP) mutations, are a model of AD amyloid-beta deposition (Abeta) that exhibits earlier and more profound impairments of working memory and learning than single APP mutant mice. In this study we compared performance on spatial memory tests, regional glucose metabolism, Abeta deposition, and neuronal loss in APP/PS1, PS1, and non-Tg (nTg) mice. At the age of 2 months no significant morphological and metabolic differences were detected between 3 studied genotypes. By 8 months, however, APP/PS1 mice developed selective impairment of spatial memory, which was significantly worse at 22 months and was accompanied by reduced glucose utilization in the hippocampus and a 35.8% dropout of neurons in the CA1 region. PS1 mice exhibited a similar degree of neuronal loss in CA1 but minimal memory deficit and no impairment of glucose utilization compared to nTg mice. Deficits in 22 month APP/PS1 mice were accompanied by a substantially elevated Abeta load, which rose from 2.5% +/- 0.4% at 8 months to 17.4% +/- 4.6%. These findings implicate Abeta or APP in the behavioral and metabolic impairments in APP/PS1 mice and the failure to compensate functionally for PS1-related hippocampal cell loss.

[1]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[2]  D. M. Feeney,et al.  Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. , 1982, Science.

[3]  Donald J. Reis,et al.  Global increase in cerebral metabolism and blood flow produced by focal electrical stimulation of dorsal medullary reticular formation in rat , 1983, Brain Research.

[4]  D. Diamond,et al.  Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes , 2001, Brain Research.

[5]  H. Meziane,et al.  Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. , 1999, Behavioral neuroscience.

[6]  H. Heller,et al.  The relationship of local cerebral glucose utilization to optical density ratios , 1983, Brain Research.

[7]  K. Duff,et al.  Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain , 2000, Neuroscience.

[8]  R. Schliebs,et al.  Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology , 2003, Journal of Neural Transmission.

[9]  I. Mitchell,et al.  In defence of optical density ratios in 2-deoxyglucose autoradiography , 1984, Brain Research.

[10]  J. Wegiel,et al.  Cell-Type-Specific Enhancement of Amyloid-β Deposition in a Novel Presenilin-1 Mutation (P117L) , 1998, Journal of neuropathology and experimental neurology.

[11]  Takeshi Iwatsubo,et al.  Animal Model Age-Related Amyloid b Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid b Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss , 2000 .

[12]  P Roullet,et al.  Detection of Object Orientation and Spatial Changes by Mice: Importance of Local Views , 1998, Physiology & Behavior.

[13]  B. Hyman,et al.  APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.

[14]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[15]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[16]  Bai Lu,et al.  Pro-Region of Neurotrophins Role in Synaptic Modulation , 2003, Neuron.

[17]  R. Schmidt-Kastner,et al.  Selective vulnerability of the hippocampus in brain ischemia , 1991, Neuroscience.

[18]  Mark J. West,et al.  New stereological methods for counting neurons , 1993, Neurobiology of Aging.

[19]  R. Schliebs,et al.  Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human β-amyloid precursor protein , 2002, Brain Research.

[20]  P. Hof.  Comparative cytoarchitectonic atlas of the C57BL/6 and 129/Sv mouse brains , 2000 .

[21]  D. Borchelt,et al.  Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins , 1995, Neuron.

[22]  M. Bobinski,et al.  Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Hardy,et al.  Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.

[24]  H Eichenbaum,et al.  Hippocampus: Mapping or memory? , 2000, Current Biology.

[25]  X. Xu,et al.  Nitro-L-arginine attenuates hypercapnic cerebrovasodilation without affecting cerebral metabolism. , 1994, The American journal of physiology.

[26]  G. Arendash,et al.  Progressive and gender-dependent cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease , 1999, Behavioural Brain Research.

[27]  B. Hyman,et al.  Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. , 2000, The American journal of pathology.

[28]  B. Sommer,et al.  Neuron loss in APP transgenic mice , 1998, Nature.

[29]  G. Alexander,et al.  Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.

[30]  K. Duff,et al.  Behavioral Changes in Transgenic Mice Expressing Both Amyloid Precursor Protein and Presenilin-1 Mutations: Lack of Association with Amyloid Deposits , 1999, Behavior genetics.

[31]  D. Quartermain,et al.  Stress-induced subsensitivity to modafinil and its prevention by corticosteroids , 2002, Pharmacology Biochemistry and Behavior.

[32]  B. Hyman,et al.  The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. , 1999, Brain : a journal of neurology.

[33]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.

[34]  Haruhisa Inoue,et al.  Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation , 1999, Nature Medicine.

[35]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[36]  D. Selkoe,et al.  Protofibrils of amyloid β-protein inhibit specific K+ currents in neocortical cultures , 2003, Neurobiology of Disease.

[37]  B. Hyman,et al.  Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.

[38]  K. Duff,et al.  Reorganization of Cholinergic Terminals in the Cerebral Cortex and Hippocampus in Transgenic Mice Carrying Mutated Presenilin-1 and Amyloid Precursor Protein Transgenes , 1999, The Journal of Neuroscience.

[39]  M. Mattson,et al.  Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders , 2002, NeuroMolecular Medicine.

[40]  V. Denenberg,et al.  Effects of Neocortical Ectopias and Environmental Enrichment on Hebb-Williams Maze Learning in BXSB Mice , 2001, Neurobiology of Learning and Memory.

[41]  J. Wegiel,et al.  Diffuse, Lake-like Amyloid-β Deposits in the Parvopyramidal Layer of the Presubiculum in Alzheimer Disease , 1998, Journal of neuropathology and experimental neurology.

[42]  S H Ferris,et al.  Motor/Psychomotor Dysfunction in Normal Aging, Mild Cognitive Decline, and Early Alzheimer's Disease: Diagnostic and Differential Diagnostic Features , 1997, International Psychogeriatrics.

[43]  Satoru Kobayashi,et al.  Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine , 2002, Journal of neuroscience research.

[44]  D. Olton,et al.  Animal Behavior Processes , 2022 .

[45]  B. Reisberg,et al.  Functional Assessment Staging (FAST) in Alzheimer's Disease: Reliability, Validity, and Ordinality , 1992, International Psychogeriatrics.

[46]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[47]  H. Tanila,et al.  Hippocampal Aβ42 Levels Correlate with Spatial Memory Deficit in APP and PS1 Double Transgenic Mice , 2002, Neurobiology of Disease.

[48]  L. Mucke,et al.  Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[49]  H. Gundersen,et al.  Unbiased stereological estimation of the number of neurons in the human hippocampus , 1990, The Journal of comparative neurology.

[50]  T. Gómez-Isla,et al.  Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Alzheimer's Disease ‐ Window on Molecular Epidemiology a , 1996, Annals of the New York Academy of Sciences.

[51]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Alescio-Lautier,et al.  Behavioral effects of arginine8-vasopressin in the Hebb–Williams maze , 2003, Behavioural Brain Research.

[53]  Antonio Caprioli,et al.  Spatial learning and memory, maze running strategies and cholinergic mechanisms in two inbred strains of mice , 1985, Behavioural Brain Research.

[54]  B. Jones,et al.  Neural remodeling in retinal degeneration , 2003, Progress in Retinal and Eye Research.

[55]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[56]  J. Hardy,et al.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.

[57]  Ling Lin,et al.  Selective Antibody-Induced Cholinergic Cell and Synapse Loss Produce Sustained Hippocampal and Cortical Hypometabolism with Correlated Cognitive Deficits , 2001, Experimental Neurology.

[58]  H. Kimura,et al.  Amyloid beta toxicity consists of a Ca(2+)-independent early phase and a Ca(2+)-dependent late phase. , 1996, Journal of Neurochemistry.

[59]  D. Diamond,et al.  Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice , 2001, Neurobiology of Aging.

[60]  D. Dickson,et al.  Amyloid Phenotype Characterization of Transgenic Mice Overexpressing both Mutant Amyloid Precursor Protein and Mutant Presenilin 1 Transgenes , 1999, Neurobiology of Disease.

[61]  B. Reisberg,et al.  The Alzheimer's Disease Activities of Daily Living International Scale (ADL-IS) , 2001, International Psychogeriatrics.

[62]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[63]  C. Kawas,et al.  The CA1 Region of the Human Hippocampus Is a Hot Spot in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[64]  D. Holtzman,et al.  Transgenic mouse brain histopathology resembles early Alzheimer's disease , 1994, Annals of neurology.

[65]  H. Wiśniewski,et al.  Pattern of neuronal loss in the rat hippocampus following experimental cardiac arrest-induced ischemia , 1999, Journal of the Neurological Sciences.

[66]  M. Mattson,et al.  Reactive Oxygen Species as Causal Agents in the Neurotoxicity of the Alzheimer's Disease‐Associated Amyloid Beta Peptide a , 1996, Annals of the New York Academy of Sciences.

[67]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[68]  Satoru Kobayashi,et al.  Effects of enriched environments with different durations and starting times on learning capacity during aging in rats assessed by a refined procedure of the Hebb‐Williams maze task , 2002, Journal of neuroscience research.

[69]  D. Quartermain,et al.  The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[70]  P. Magistretti,et al.  Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[71]  J. Wegiel,et al.  Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease , 1998, Brain Research.

[72]  L. Sokoloff,et al.  Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. , 2003, Endocrinology.